Skip to main content

Table 1 Characteristics of the study population, and compliance with daily application of study cream

From: A phase i study of daily treatment with a ceramide-dominant triple lipid mixture commencing in neonates

Male infant 6/10
Number of parents with allergic disease  
1 parent 9/10
2 parents 1/10
Age in weeks at: Median (IQR)*
commencement of treatment 2.1 (1.3-2.9)
follow-up 9.5 (7.6-10.1)
Application of study cream - medians (range)  
days cream applied (max = 42) 38.5 days (35-42)
proportion of eligible days applied 92% (83%-100%)
total quantity applied 158 g (150-207)
average quantity applied per day 3.8 g (3.6-4.9)
average quantity applied per day on days used 4.4 g (3.8-4.9)
  1. *IQR interquartile range.